Corporate Profile
| Company Name | Japan Tissue Engineering Co., Ltd. (J-TEC) |
|
|---|---|---|
| Establishment | February 1, 1999 | |
| Capitalization | 5,714.95 million yen | |
| Business groups |
|
|
| Executives | President and CEO: | Yosuke Ozawa |
| Senior Managing Director: | Toshihiro Osuka | |
| Managing Director: | Ken-ichiro Hata, D.D.S., Ph.D. | |
| Directors: | Yukio Mori, Toru Kuroda, Masahito Obayashi, Kunihiro Nomura, Kiyotaka Kurahashi, Katsumitsu Nakamura | |
| Auditors: | Isamu Kobayashi, Takahiro Kato, Syun-ichiro Ishikawa | |
| Headquarters | 6-209-1 Miyakitadori, Gamagori, Aichi 443-0022, Japan TEL: +81-533-66-2020 FAX: +81-533-66-2019 e-mail:jtec-info@jpte.co.jp |
|
| Financial year ends | March | |
Company History
| Feb. 1999 | Japan Tissue Engineering Co., Ltd established. Operations begun at Hama-cho, Gamagori. |
|---|---|
| Sep. 1999 | Relocated the head office to Miyakidadori, Gamagori. |
| Nov. 2000 | Awarded the Chubu Bureau of International Trade and Industry Prize in the New Business Awards Division of the Chubu New Business Awards, sponsored by the Chubu New Business Association. | Dec. 2000 | Submitted application for government approval prior to a clinical trial of Autologous Cultured Epidermis. | Sept. 2001 | Submitted application for government approval prior to a clinical trial of Autologous Cultured Cartilage. |
| Jan. 2002 | Awarded a Special Incentive Award in the 15th Chunichi Industrial Technology Awards sponsored by the Chunichi Shimbun newspaper. |
| Mar. 2002 | Obtained authorization to begin clinical trials of autologous cultured epidermis. |
| Aug. 2003 | Full-scale entry into cornea cultivation in collaboration with an Italian eye bank (The Veneto Eye Bank Foundation). |
| Sep. 2003 | Started multicenter clinical trials of autologous cultured epidermis. |
| Feb. 2004 | Obtained authorization to begin clinical trials of autologous cultured cartilage. |
| May 2004 | Started multicenter clinical trials of autologous cultured cartilage. |
| Jun. 2004 | Awarded President of the Science Council of Japan's Award at the 16th Awards for Excellence in Collaboration Between Industry, Academia, and Government. |
| Oct. 2004 | Submitted application for manufacturing and sales approval of Autologous Cultured Epidermis. |
| Nov. 2004 | Completed construction of new premises and moved in. |
| Mar. 2005 | Launched sales of LabCyte EPI-MODEL, a cultured human tissue for research use. |
| Oct. 2005 | Awarded the Japan Bioventure Grand Prize, the top honor in the Fourth Japan Bioventure Grand Prize awards. |
| Nov. 2006 | Awarded the highest prize in the New Business Awards 2006, sponsored by the Chubu Economic Federation. |
| Nov. 2006 | Launched sales of LabCyte MELANO-MODEL, a cultured human tissue for research use. |
| Mar. 2007 | Submitted clinical trial completion notification of Autologous Cultured Cartilage. | May. 2007 | Submitted application for government approval prior to a clinical trial of Autologous Cultured Corneal Epithelium. |
| Oct. 2007 | Received government approval to culture and sell Autologous Cultured Epidermis JACE® for serious burns treatment in Japan. |
| Nov. 2007 | Submitted a request for health insurance listing of Autologous Cultured Epidermis. |
| Dec. 2007 | Joined the JASDAQ Securities Exchange's Neo market on December 21. |
| May 2008 | Entered into an Advisory Agreement with Prof. Howard Green of Harverd Medical School. |
| Jan. 2009 | Autologous Cultured Epidermis "JACE": Listed as an item covered by the National Health Insurance in Japan. |
| Aug. 2009 | Submitted application for manufacturing and sales of Autologous Cultured Cartilage. |